| Intrinsic Valuation of: PIDILITIND | |||||||||||
| Free Cash Flow Average and Growth over past 5Y | Key Statistics | ||||||||||
| Year | FCF | FCF (FCF/Revenue) | |||||||||
| 2021 | - | - | EPS (FY) | 24 | Market Cap | ₹1,494B | |||||
| 2022 | - | - (-) | P/E Ratio | 61 | Total Asset | ₹154B | |||||
| 2023 | ₹11B | - (-) | Net Income | ₹24B | Total Debt | ₹0 | |||||
| 2024 | ₹22B | 105.8% (96.0%) | EBITDA | ₹38B | Total Liab | ₹44B | |||||
| 2025 | ₹18B | -15.3% (-20.5%) | Opr Margin | 21.40 | Debt/Equity | - | |||||
| 2026 | ₹22B | 21.9% (9.7%) | PreTax Margin | 21.03 | BV/Share | 78 | |||||
| 5Y Average FCF | ₹18B | 15.0% (28.4%) | |||||||||
| Overall Market Assumptions: | |||||||||||
| Assumptions: | P/E for No-Growth Company: | 7.0 | |||||||||
| Perpetual Growth Rate (g): | 2.48% | Historical US Bond Yield: | 4.40% | ||||||||
| Discount Rate (WACC): | 7.00% | Current US Bond Yield: | 3.48% | ||||||||
| Forcasting Future Free Cash Flow for next 6Y | Modified Benjamin Graham's Intrinsic Value | ||||||||||
| Year | FCF Projection (15.0%) | ||||||||||
| 2027 | ₹24B | MBG Intrinsic Value | ₹215 | ||||||||
| 2028 | ₹27B | ||||||||||
| 2029 | ₹30B | ||||||||||
| 2030 | ₹32B | ||||||||||
| 2031 | ₹34B | ||||||||||
| 2032 | ₹35B | ||||||||||
| Terminal Value | ₹788B | Net Worth/Share | ₹109 | ||||||||
| DCF Valuation | DCF Valuation "What If" Scenario Table | ||||||||||
| Enterprise Value | ₹668B | Growth Rate | |||||||||
| (+) Cash & Cash Equivalents | ₹2B | ₹659 | 1.5% | 2.0% | 2.5% | 3.0% | 3.5% | ||||
| (-) Total Debt | ₹0 | WACC | 6.5% | 618 | 673 | 742 | 830 | 947 | |||
| Equity Value | ₹670B | 7.1% | 549 | 591 | 641 | 704 | 785 | ||||
| Shares Outstanding | 1,017,775,348 | 7.8% | 493 | 525 | 564 | 610 | 668 | ||||
| 8.4% | 446 | 472 | 503 | 538 | 582 | ||||||
| DCF Intrinsic Value | ₹659 | 9.0% | 409 | 430 | 454 | 482 | 516 | ||||
| Analyzed by QuantJuice (2025) | |||||||||||